Monopar Therapeutics Inc. (MNPR)
NASDAQ·Healthcare·Biotechnology
$59.50
+0.68%
Mkt Cap $398.46M
Analyst Ratings
Buy
5
Hold
0
Sell
0
Price Target (14 analysts)
$115.00
Range $115.00 – $115.00
Implied Upside
+93.3%
Consensus $115.00 vs current $59.50
NASDAQ·Healthcare·Biotechnology
$59.50
+0.68%
Mkt Cap $398.46M
Buy
5
Hold
0
Sell
0
Price Target (14 analysts)
$115.00
Range $115.00 – $115.00
+93.3%
Consensus $115.00 vs current $59.50